phageendolysins.wordpress.com
phageendolysins | Just another WordPress.com siteJust another WordPress.com site
http://phageendolysins.wordpress.com/
Just another WordPress.com site
http://phageendolysins.wordpress.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Monday
LOAD TIME
0.6 seconds
16x16
32x32
64x64
PAGES IN
THIS WEBSITE
17
SSL
EXTERNAL LINKS
11
SITE IP
192.0.78.13
LOAD TIME
0.625 sec
SCORE
6.2
phageendolysins | Just another WordPress.com site | phageendolysins.wordpress.com Reviews
https://phageendolysins.wordpress.com
Just another WordPress.com site
phageendolysins.wordpress.com
Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection | phageendolysins
https://phageendolysins.wordpress.com/2012/03/25/lysis-deficient-phages-as-novel-therapeutic-agents-for-controlling-bacterial-infection
Aims of this research field. Just another WordPress.com site. Laquo; Antibacterial and biofilm removal activity of a podoviridae Staphylococcus aureus bacteriophage SAP-2 and a derived recombinant cell-wall-degrading enzyme. Novel Chimerical Endolysins with Broad Antimicrobial Activity Against Methicillin-Resistant Staphylococcus aureus. Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection. March 25, 2012 by phageendolysins. What sort of advantages would it bring? You ar...
Novel Chimerical Endolysins with Broad Antimicrobial Activity Against Methicillin-Resistant Staphylococcus aureus | phageendolysins
https://phageendolysins.wordpress.com/2012/04/30/novel-chimerical-endolysins-with-broad-antimicrobial-activity-against-methicillin-resistant-staphylococcus-aureus
Aims of this research field. Just another WordPress.com site. Laquo; Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection. Mycobacteriophage endolysins diverse and modular enzymes with multiple catalytic activities. Novel Chimerical Endolysins with Broad Antimicrobial Activity Against Methicillin-Resistant Staphylococcus aureus. April 30, 2012 by phageendolysins. Gram positive bacteriophage endolysins are recognize to have modular organizations. Site-directed cloning...
April | 2012 | phageendolysins
https://phageendolysins.wordpress.com/2012/04
Aims of this research field. Just another WordPress.com site. Archive for April, 2012. Novel Chimerical Endolysins with Broad Antimicrobial Activity Against Methicillin-Resistant Staphylococcus aureus. On April 30, 2012 Leave a Comment. Gram positive bacteriophage endolysins are recognize to have modular organizations. Site-directed cloning have shown that these domains are independent and can be fused with exogenous domains in order to seek increase bacterial lytic action. Although the antimicro...Struc...
February | 2012 | phageendolysins
https://phageendolysins.wordpress.com/2012/02
Aims of this research field. Just another WordPress.com site. Archive for February, 2012. Antibacterial and biofilm removal activity of a podoviridae Staphylococcus aureus bacteriophage SAP-2 and a derived recombinant cell-wall-degrading enzyme. On February 19, 2012 Leave a Comment. Biofilm removal study using the bacteriophage Φ11 lysin (Sass and Bierbaum 2007), this article is the second reported study of an antibacterial and biofilm removal activity of the. First, isolation of a biofilm-forming. Rapid...
April | 2013 | phageendolysins
https://phageendolysins.wordpress.com/2013/04
Aims of this research field. Just another WordPress.com site. Archive for April, 2013. Rapid degradation of Streptococcus pyogenes biofilms by PlyC, a bacteriophage-encoded endolysin. On April 9, 2013 Leave a Comment. Biofilm control by a bacteriophage-encoded endolysin PlyC. Read Full Post ». Follow Blog via Email. Enter your email address to follow this blog and receive notifications of new posts by email. Join 6 other followers. Characterization of five novel endolysins from Gram-negative infecting bact...
TOTAL PAGES IN THIS WEBSITE
17
Structure of Proteus mirabilis biofilms grown in artificial urine and standard laboratory media | Biofilm Therapy
https://biofilmtherapy.wordpress.com/2012/05/10/structure-of-proteus-mirabilis-biofilms-grown-in-artificial-urine-and-standard-laboratory-media
Aims of this research field. With this blog I have got the intention of emphasize and discuss some of the articles that I consider more relevant in my PhD theme. May 10, 2012. Structure of Proteus mirabilis biofilms grown in artificial urine and standard laboratory media. Is a common urinary tract infectious agent. This organism has the ability to alkalinize the urine and under this condition forms crystals (e.g. magnesium phosphate) and adheres to catheter surfaces forming biofilms. At 12h, biofilms gro...
Isolation and characterization of ZZ1, a novel lytic phage that infects Acinetobacter baumanii clinical isolates | Biofilm Therapy
https://biofilmtherapy.wordpress.com/2012/11/22/isolation-and-characterization-of-zz1-a-novel-lytic-phage-that-infects-acinetobacter-baumanii-clinical-isolates
Aims of this research field. With this blog I have got the intention of emphasize and discuss some of the articles that I consider more relevant in my PhD theme. November 22, 2012. Isolation and characterization of ZZ1, a novel lytic phage that infects Acinetobacter baumanii clinical isolates. Is a bacteria responsible for innumerous nosocomial infections being resistant to common antibiotics. In this particular study, clinical isolates were used to screen phages from water samples. PH and temperature st...
Purification and concentration of Mycobacteriophage D29 using monolithic chromatographic columns | Biofilm Therapy
https://biofilmtherapy.wordpress.com/2012/08/31/purification-and-concentration-of-mycobacteriophage-d29-using-monolithic-chromatographic-columns
Aims of this research field. With this blog I have got the intention of emphasize and discuss some of the articles that I consider more relevant in my PhD theme. August 31, 2012. Purification and concentration of Mycobacteriophage D29 using monolithic chromatographic columns. Before purify the phages with CIM monolithic columns a previous primary purification step is needed. The recovery rates obtained with PEG 8000 and ammonium sulphate precipitation were comparable. Additionally, the total protein depl...
Lytic activity of the virio-associated peptidoglycan hydrolase HydH5 of Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88 | Biofilm Therapy
https://biofilmtherapy.wordpress.com/2012/01/30/lytic-activity-of-the-virio-associated-peptidoglycan-hydrolase-hydh5-of-staphylococcus-aureus-bacteriophage-vb_saus-phiipla88
Aims of this research field. With this blog I have got the intention of emphasize and discuss some of the articles that I consider more relevant in my PhD theme. January 30, 2012. Lytic activity of the virio-associated peptidoglycan hydrolase HydH5 of Staphylococcus aureus bacteriophage vB SauS-phiIPLA88. In this article, the authors described the structural endolysin of the previously characterized. Bacteriophage vB SauS-phiIPLA88 (phiIPLA88), belonging to. Are similar to those infecting. Additionally, ...
About Me | Biofilm Therapy
https://biofilmtherapy.wordpress.com/about
Aims of this research field. With this blog I have got the intention of emphasize and discuss some of the articles that I consider more relevant in my PhD theme. My name is Luís Melo, I’m a Biologist. Currently I’m a PhD student, doing Doctoral Program in Biomedical Engineering at the University of Minho, Braga, Portugal. My PhD thesis is focused on the finding of new. Specific bacteriophages and their characterization. I also want to analyze their action on. At the Centre of Biological Engineering.
Biofilm Therapy | With this blog I have got the intention of emphasize and discuss some of the articles that I consider more relevant in my PhD theme. | Page 2
https://biofilmtherapy.wordpress.com/page/2
Aims of this research field. With this blog I have got the intention of emphasize and discuss some of the articles that I consider more relevant in my PhD theme. December 31, 2011. The use of lytic bacteriophages in the prevention and eradication of biofilms of Proteus mirabilis and Escherichia coli. The increase dependence on indwelling medical devices that are commonly susceptible to biofilm-associated infections has led to a constant increase on the rates of nosocomial infections. November 9, 2011.
Disruption of Staphylococcus epidermidis biofilm formation using a targeted cationic peptide | Biofilm Therapy
https://biofilmtherapy.wordpress.com/2012/02/27/disruption-of-staphylococcus-epidermidis-biofilm-formation-using-a-targeted-cationic-peptide
Aims of this research field. With this blog I have got the intention of emphasize and discuss some of the articles that I consider more relevant in my PhD theme. February 27, 2012. Disruption of Staphylococcus epidermidis biofilm formation using a targeted cationic peptide. Biofilm formation, PIA is a cationic molecule responsible for association with negatively charged surfaces. In this study the authors wanted to use a targeted cationic peptide with the goal to disrupt electrostatic interaction between.
Pros and cons of phage therapy | Biofilm Therapy
https://biofilmtherapy.wordpress.com/2012/03/31/pros-and-cons-of-phage-therapy
Aims of this research field. With this blog I have got the intention of emphasize and discuss some of the articles that I consider more relevant in my PhD theme. March 31, 2012. Pros and cons of phage therapy. This publication compiles a list of advantages and disadvantages of phage therapy. The authors suggest as the bigger advantages of phages instead the use of antibiotics the following features:. 8211; Obligate lytic phages are bactericidal. 8211; Phages have the ability of auto-dosing. 8211; Not all...
Genomic characterization of two Staphylococcus epidermidis bacteriophages with anti-biofilm potential | Biofilm Therapy
https://biofilmtherapy.wordpress.com/2012/12/03/genomic-characterization-of-two-staphylococcus-epidermidis-bacteriophages-with-anti-biofilm-potential
Aims of this research field. With this blog I have got the intention of emphasize and discuss some of the articles that I consider more relevant in my PhD theme. December 3, 2012. Genomic characterization of two Staphylococcus epidermidis bacteriophages with anti-biofilm potential. Strains. Both phages presented similarities with other two S. epidermidis. Phi-IPLA5 possesses an unique lysis region, particulary in the holin endoding orf, which has no similarity within other S. epidermidis. Both phages pre...
TOTAL LINKS TO THIS WEBSITE
11
Phage Display - Screening of phage libraries as antibody libraries or peptide library.
Screening of Phage Display Libraries. What is a phage or bacteriophage? Phages are viruses that infect bacterial cells. There are several types of phages that have been used as vehicles for phage display including Ff filamentous phage, Lambda and T7. In phage display, the bacteriophages are used to construct different phage libraries as peptide libraries or antibody library. History of phage display. Advantages of phage display. Phage Display technology review. Protein libraries and antibody libraries.
phagedisplay.org
Ce nom de domaine n'est pas disponible. Il a été enregistré via gandi.net. More information about the owner. Enregistrer votre nom de domaine. Chez Gandi, vous avez le choix sur plus d'une centaine d'extensions et vous bénéficiez de tous les services inclus (mail, redirection, ssl.). Rechercher un nom de domaine. Votre site dans le cloud? Découvrez Simple Hosting, notre cloud en mode PaaS à partir de 4 HT par mois (-50% la première année pour les clients domaine). It is currently being parked by the owner.
phagedoctor.com - phagedoctor Resources and Information.
This webpage was generated by the domain owner using Sedo Domain Parking. Disclaimer: Sedo maintains no relationship with third party advertisers. Reference to any specific service or trade mark is not controlled by Sedo nor does it constitute or imply its association, endorsement or recommendation.
Error!
The current username, password or host was not accepted when the connection to the database was attempted to be established!
phagedrugs.com - phagedrugs Resources and Information.
This webpage was generated by the domain owner using Sedo Domain Parking. Disclaimer: Sedo maintains no relationship with third party advertisers. Reference to any specific service or trade mark is not controlled by Sedo nor does it constitute or imply its association, endorsement or recommendation.
phageendolysins | Just another WordPress.com site
Aims of this research field. Just another WordPress.com site. Rapid degradation of Streptococcus pyogenes biofilms by PlyC, a bacteriophage-encoded endolysin. April 9, 2013 by phageendolysins. Biofilm control by a bacteriophage-encoded endolysin PlyC. Continue Reading ». Listeria bacteriophage peptidoglycan hydrolases feature high thermoresistance and reveal increased activity after divalent metal cation substitution. December 4, 2012 by phageendolysins. In this article we give an example of how phage endo...
Intralytix, Inc. - Home
Intralytix is using its core bacteriophage technology to develop novel natural products for use in food processing, environmental clean-up, sanitation, consumer products, and problems of antibiotic resistance in human therapy. Is a biotechnology company focused on the production and marketing of bacteriophage-based products to control bacterial pathogens in environmental, food processing, and medical settings. Health Canada approved the use of ListShield as a processing aid for ready-to-eat meat a...
Intralytix, Inc. - Home
Intralytix is using its core bacteriophage technology to develop novel natural products for use in food processing, environmental clean-up, sanitation, consumer products, and problems of antibiotic resistance in human therapy. Is a biotechnology company focused on the production and marketing of bacteriophage-based products to control bacterial pathogens in environmental, food processing, and medical settings. Health Canada approved the use of ListShield as a processing aid for ready-to-eat meat a...
Intralytix, Inc. - Home
Intralytix is using its core bacteriophage technology to develop novel natural products for use in food processing, environmental clean-up, sanitation, consumer products, and problems of antibiotic resistance in human therapy. Is a biotechnology company focused on the production and marketing of bacteriophage-based products to control bacterial pathogens in environmental, food processing, and medical settings. Health Canada approved the use of ListShield as a processing aid for ready-to-eat meat a...
Intralytix, Inc. - Home
Intralytix is using its core bacteriophage technology to develop novel natural products for use in food processing, environmental clean-up, sanitation, consumer products, and problems of antibiotic resistance in human therapy. Is a biotechnology company focused on the production and marketing of bacteriophage-based products to control bacterial pathogens in environmental, food processing, and medical settings. Health Canada approved the use of ListShield as a processing aid for ready-to-eat meat a...
Intralytix, Inc. - Home
Intralytix is using its core bacteriophage technology to develop novel natural products for use in food processing, environmental clean-up, sanitation, consumer products, and problems of antibiotic resistance in human therapy. Is a biotechnology company focused on the production and marketing of bacteriophage-based products to control bacterial pathogens in environmental, food processing, and medical settings. Health Canada approved the use of ListShield as a processing aid for ready-to-eat meat a...
